Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

BACKGROUND: Myasthenia gravis (MG) is a rare but life-threatening adverse event of immune checkpoint inhibitors (ICI). Given the limited evidence, data from a large cohort of patients is needed to aid in recognition and management of this fatal complication. METHODS: We reviewed our institutional da...

Descripción completa

Detalles Bibliográficos
Autores principales: Safa, Houssein, Johnson, Daniel H, Trinh, Van Anh, Rodgers, Theresa E, Lin, Heather, Suarez-Almazor, Maria E, Fa’ak, Faisal, Saberian, Chantal, Yee, Cassian, Davies, Michael A, Tummala, Sudhakar, Woodman, Karin, Abdel-Wahab, Noha, Diab, Adi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868691/
https://www.ncbi.nlm.nih.gov/pubmed/31753014
http://dx.doi.org/10.1186/s40425-019-0774-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868691/
https://www.ncbi.nlm.nih.gov/pubmed/31753014
http://dx.doi.org/10.1186/s40425-019-0774-y

Ejemplares similares